Rogelio Cuevas-Lopez
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Matrix metalloproteinase 10 is linked to the risk of progression to dementia of the Alzheimer's type.
Journal: Brain : a journal of neurology
Published: August 16, 2021
Neuropsychiatric Profile as a Predictor of Cognitive Decline in Mild Cognitive Impairment.
Journal: Frontiers in aging neuroscience
Published: June 01, 2021
From Face-to-Face to Home-to-Home: Validity of a Teleneuropsychological Battery.
Journal: Journal of Alzheimer's disease : JAD
Published: May 03, 2021
Combination of white matter hyperintensities and Aβ burden is related to cognitive composites domain scores in subjective cognitive decline: the FACEHBI cohort.
Journal: Alzheimer's research & therapy
Published: March 02, 2021
Metabolomics study to identify plasma biomarkers in alzheimer disease: ApoE genotype effect.
Journal: Journal of pharmaceutical and biomedical analysis
Published: October 24, 2019
Lipid peroxidation biomarkers correlation with medial temporal atrophy in early Alzheimer Disease.
Journal: Neurochemistry international
Published: June 03, 2019
Plasma metabolomics in early Alzheimer's disease patients diagnosed with amyloid biomarker.
Journal: Journal of proteomics
Published: January 07, 2019
New screening approach for Alzheimer's disease risk assessment from urine lipid peroxidation compounds.
Journal: Scientific reports
Published: August 26, 2018
Plasma lipid peroxidation biomarkers for early and non-invasive Alzheimer Disease detection.
Journal: Free radical biology & medicine
Published: April 20, 2018
Last Updated: 09/26/2026